C-reactive protein and rapidly progressive coronary artery disease--is there any relation?

Related Experiment Video

Updated: Sep 27, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Michael N Zairis1, Stavros J Manousakis, Alexander S Stefanidis

  • 1Department of Cardiology, Tzanio Hospital, Piraeus, Greece. zairis66@yahoo.gr

Clinical Cardiology
|March 11, 2003
PubMed

Insights

High C-reactive protein (CRP) levels are linked to rapid progression of coronary artery disease (CAD). Elevated CRP identifies patients at higher risk for developing new or worsening atherosclerotic lesions.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Medical Diagnostics

Background:

  • High C-reactive protein (CRP) levels are associated with poor outcomes in coronary artery disease (CAD).
  • CRP's direct role in atherosclerosis progression is hypothesized.
  • Understanding CRP's impact on CAD progression is crucial for patient management.

Purpose of the Study:

  • To investigate the association between elevated plasma CRP levels and rapid progression of coronary atherosclerosis (RPCAD).
  • To determine if CRP can serve as a predictive marker for accelerated atherosclerotic development.

Main Methods:

  • Studied 194 patients readmitted for symptom recurrence post-percutaneous coronary intervention.
  • Utilized repeat coronary angiography with a median follow-up of 6 months.
  • Defined RPCAD as new lesions (>25% stenosis) or significant deterioration of existing lesions.

Main Results:

  • Multivariate analysis revealed higher risk of RPCAD in patients with elevated CRP.
  • Patients with CRP 0.5-2 mg/dl had an odds ratio (OR) of 1.8 for RPCAD.
  • Patients with CRP > 2 mg/dl showed a significantly higher OR of 7.1 for RPCAD.

Conclusions:

  • Increased plasma CRP levels may identify patients at high risk for developing RPCAD.
  • CRP could be a valuable biomarker for predicting accelerated atherosclerosis.
  • Further research may elucidate CRP's specific mechanisms in CAD progression.
Abstract

More Related Videos

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...